Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39758979 in Adult Japanese Subjects With Moderate Atopic Dermatitis
NCT01497119Phase 2Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JNJ-39758979 in atopic dermatitis (AD), sponsored by Janssen Pharmaceutical. Started Oct 2011; status: terminated.
02
Drugs
JNJ-39758979
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01497119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497119.